Article Details
Retrieved on: 2018-01-24 09:07:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Vanguard Group</b> Inc. grew its position in AVEO Pharmaceuticals by 48.6% in the second quarter. <b>Vanguard Group</b> Inc. now owns 3,551,360 shares of the biopharmaceutical company's stock worth $7,884,000 after acquiring an additional 1,162,232 shares in the last quarter. EAM Investors LLC ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here